STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-06-14
Here’s whether Cerus Corp (CERS) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+7.86% over 10 days); RSI 43 — healthy momentum range; strong 1-year return of +86.9%; 3-month momentum positive (+42.2%). Concerns: declining volume on rally — weak conviction (0.73x 30d avg). Currently 18.7% off its 52-week high. Score: +6/7.
CERS is in a confirmed uptrend, trading above both its 50-day ($2.37) and 200-day ($1.99) moving averages. An RSI of 43.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +86.9% compares to +22.9% for SPY (beat the market by 64.0%).
$10,000 invested 1 year ago→ $18,686 today
vs. S&P 500 (SPY) — same period beat market by 64.0%